Novel pharmaceutical composition for anaplastic thyroid carcinoma
|Title||Novel pharmaceutical composition for anaplastic thyroid carcinoma|
|Profile Type||Technology Offer|
A Korean company specialised in biomedical science has developed a new treatment for anaplastic thyroid carcinoma. The new pharmaceutical composition will enable to cure undifferentiated thyroid cancer. The company is looking for partners to make license agreement with or progress joint research and development.
|Type and Role of Partner Sought|
Type of partner sought
Specific area of activity of partner
Tasks to be performed by the partner sought
|Type of Partnership Considered|
License Agreement, Research Cooperation Agreement
|Technology Keyword||aromatic , cancerology , chemical , cytology , drug , emergency , medicine , oncology , pharmaceutical , spices , vaccine|
|EEN Application File||EEN Application File TOKR20170321001.PDF |
The profile provides the summary only. For the profile details, please download the application file in PDF.